PTAB challenges

Proceedings overview

There are no AIA trial proceedings on file for US Patent 7,280,830 as of the most recent ingest. A web search also did not reveal any active or concluded PTAB proceedings specifically challenging US7280830. Therefore, for a defendant, the defensive posture is that the patent is currently untested in AIA trial proceedings, meaning all claims remain intact from a PTAB challenge perspective.

Strategic summary

All claims of US Patent 7,280,830 are currently UNTESTED in AIA trial proceedings. No Inter Partes Reviews (IPRs), Post-Grant Reviews (PGRs), or Covered Business Method (CBM) reviews have been identified for this patent. This means that a defendant facing assertion of this patent still has all prior-art grounds available under § 102 (novelty) and § 103 (obviousness) in any potential PTAB challenge, as well as grounds under § 112 (written description, enablement, indefiniteness) in a PGR if timely filed.

The absence of PTAB activity is notable, especially given the patent's publication date of 2007-10-09. Well-asserted patents often become targets for IPRs or other post-grant challenges. This could indicate that the patent has not been heavily asserted in litigation, or that previous challenges (perhaps through other avenues like reexamination) did not proceed to AIA trials. There is no indication of any defensive aggregators like Unified Patents having challenged this specific patent. Unified Patents files IPRs to deter Non-Practicing Entities (NPEs) and protects members from frivolous patent litigation.

Recommended next steps

Since no PTAB activity exists for US Patent 7,280,830, a defendant has the full range of options available for challenging the patent's validity before the USPTO should they decide to do so. This includes:

• Inter Partes Review (IPR): If the defendant has been sued or charged with infringement, an IPR can be filed to challenge the patentability of claims based on prior art patents or printed publications under § 102 and § 103.
• Post-Grant Review (PGR): While the 9-month window for filing a PGR from the patent's issuance has long passed (the patent issued in 2007), it's important to note that PGR allows for challenges on any ground of invalidity, including §§ 101, 102, 103, and 112 (except best mode).
• Covered Business Method (CBM) Review: The CBM program sunsetted for new petitions on September 16, 2020. However, for context, CBM reviews were available for patents claiming methods or systems for financial products or services and allowed challenges on various grounds, including § 101. This patent would not be eligible for a new CBM petition.

The absence of PTAB activity means there are no ongoing trial-stage milestones to track. The first step for a defendant considering a PTAB challenge would be to conduct a thorough prior art search and invalidity analysis to identify strong grounds for a petition.